greatatlanticImg205062019

You may have missed

ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer

Alvotech Enters into Exclusive Licensing Agreement with Kashiv BioSciences for Development and Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)

Alvotech Enters into Exclusive Licensing Agreement with Kashiv BioSciences for Development and Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)

TD SYNNEX Report: AI Offerings Grow 625% Globally in One Year among Technology Resellers

FendX Successfully Completes Pilot Run to Manufacture REPELWRAP(TM) Film using Dunmore’s Commercial Equipment

error: Content is protected !!